利用目前对IL-10产生树突细胞的洞察力,开发有效的免疫治疗方法
Konstantina Morali1, Gloria Giacomello1,2, Michela Vuono1,3
1Mechanisms of Peripheral Tolerance Unit, San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, Italy.
FEBS letters
|September 12, 2024
概括
耐受性树突细胞 (tolDC) 是免疫耐受性的关键. 本综述强调了体外生成的tolDC,特别是用IL-10调节的tolDC,如何有效地促进治疗应用的调节性T细胞.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 治疗开发的治疗方法
背景情况:
- 树突细胞 (DC) 是重要的抗原呈现细胞,调节免疫反应.
- 宽容性树突细胞 (tolDC) 维持组织平衡,并诱导耐受性.
- tolDC对于治疗免疫媒介疾病具有前景.
研究的目的:
- 审查关于健康和疾病中tolDC的当前知识.
- 专注于IL-10调节以进行体外tolDC生成.
- 探索tolDC的分子,代谢和功能概况.
主要方法:
- 从外围血液单细胞生成tolDC的体外生成概述.
- 专注于IL-10调节作为一种高效的方法.
- 分子,代谢和功能特征的分析.
主要成果:
- 对于产生强大的tolDC,IL-10调节非常有效.
- 在体外生成的tolDC调节T细胞动态,有利于调节性T细胞 (Tregs).
- 调节IL-10的tolDC促进具有强烈抑制活性的Tregs.
结论:
- tolDC对于在免疫媒介疾病中重新建立耐受性具有吸引力.
- 了解tolDC通路对于它们的免疫调节功能至关重要.
- 对tolDC生成和临床应用的进一步研究是有必要的.
相关概念视频
01:27Tumor Immunotherapy
491
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
491
01:24T Cell Types and Functions
961
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
961